InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Discover the detailed record of transactions filed by Knowles Julius, Director. Officer active across 1 companies, notably Keros Therapeutics, Inc.. Cumulatively, 22 reports have been published. Total volume traded: €5.4m. The latest transaction was filed on 3 January 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations22 total
€183,7473,678 shares@ €49.95840.030% mcap3.4% of flow
Common Stock
SEC:0001209191-22-001990:0·
€183,7473,678 shares@ €49.95840.030% mcap7.2% of flow
Common Stock
SEC:0001209191-22-001990·
€200,2734,243 shares@ €47.20090.032% mcap7.8% of flow
Common Stock
SEC:0001209191-21-067877·
€200,2734,243 shares@ €47.20090.032% mcap3.7% of flow
Common Stock
SEC:0001209191-21-067877:0·
€255,5547,057 shares@ €36.21280.041% mcap10.0% of flow
Common Stock
SEC:0001209191-21-062812·
€255,5547,057 shares@ €36.21280.041% mcap4.8% of flow
Common Stock
SEC:0001209191-21-062812:0·
€66,3722,029 shares@ €32.71160.011% mcap2.6% of flow
Common Stock
SEC:0001209191-21-061256·
€66,3722,029 shares@ €32.71160.011% mcap1.2% of flow
Common Stock
SEC:0001209191-21-061256:0·
€91,8472,653 shares@ €34.62010.015% mcap3.6% of flow
Common Stock
SEC:0001209191-21-060784·
€91,8472,653 shares@ €34.62010.015% mcap1.7% of flow
Common Stock
SEC:0001209191-21-060784:0·
€132,7863,827 shares@ €34.6970.021% mcap5.2% of flow
Common Stock
SEC:0001209191-21-059749·
€132,7863,827 shares@ €34.6970.021% mcap2.5% of flow
Common Stock
SEC:0001209191-21-059749:0·
€948,02127,373 shares@ €34.63340.15% mcap37.1% of flow
Common Stock
SEC:0001209191-21-058061·
€948,02127,373 shares@ €34.63340.15% mcap17.7% of flow
Common Stock
SEC:0001209191-21-058061:0·
€461,67213,268 shares@ €34.79590.074% mcap18.1% of flow
Common Stock
SEC:0001209191-21-045620·
€461,67213,268 shares@ €34.79590.074% mcap8.6% of flow
Common Stock
SEC:0001209191-21-045620:0·
€116,3132,988 shares@ €38.92690.019% mcap4.6% of flow
Common Stock
SEC:0001209191-21-038917·
€116,3132,988 shares@ €38.92690.019% mcap2.2% of flow
Common Stock
SEC:0001209191-21-038917:0·
€98,0842,309 shares@ €42.47910.016% mcap3.8% of flow
Common Stock
SEC:0001209191-21-037974·
€98,0842,309 shares@ €42.47910.016% mcap1.8% of flow
Common Stock
SEC:0001209191-21-037974:0·
€250,1095,383 shares@ €46.46280.040% mcap4.7% of flow
Common Stock
SEC:0001209191-21-030410:0·
5,383 shares
Common Stock
SEC:0001209191-21-030410·
22 of 22 declarations
About Knowles Julius
Knowles Julius is a director at Keros Therapeutics, Inc.
